Navigation Links
Orchid Cellmark to Present at the 2008 Bank of America Health Care Conference
Date:5/12/2008

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (Nasdaq: ORCH) today announced that Thomas A. Bologna, President and Chief Executive Officer of Orchid, is scheduled to present at the 2008 Bank of America Health Care Conference in Las Vegas on Wednesday, May 14, 2008 at 3:20 p.m. PDT.

Mr. Bologna will provide a brief corporate overview and discuss the company's recent and ongoing progress. A link to the live webcast of Mr. Bologna's presentation will be available in the Investors/Calendar of Events section of the company's website at http://www.orchid.com. The webcast will be archived through May 30, 2008.

About Orchid Cellmark

Orchid Cellmark is a leading provider of identity DNA testing services for the human identity and agriculture markets. In the human identity area, the company provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid Cellmark provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these segments reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark brand that has been associated with exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at http://www.orchid.com.

Contact:

Orchid Cellmark Inc.

(609) 750-2324

Mary Bashore

Investor Relations


'/>"/>
SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. First orchid fossil puts showy blooms at some 80 million years old
2. Heart of Herschel to be presented to media
3. Frontiers in Optics presents scientific advancements
4. Male contraception breakthroughs to be presented, Seattle Sept. 27-28
5. New book presents successful strategies for probing genetic variation
6. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
7. Chemical compound present in detergents produce bacteria alterations in agricultural soils
8. New book presents methods to poke and prod individual molecules
9. Present-day species of piranha result from a marine incursion into the Amazon Basin
10. Roger Kornberg to present lecture at the Joint Biophysical Society/IUPAB Meeting
11. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... the prestigious international IAIR Award for the most innovative high security ePassport ... ... Maldives Immigration Controller General, Mr. ... on the right) have received the IAIR award for the "Most innovative ...
Breaking Biology News(10 mins):
(Date:6/14/2017)... ... June 14, 2017 , ... Slone ... the initiative steered by the executive search firm, “Building Value in Precision Medicine: ... of Directors of Foundation Medicine, led an open discussion with expert panelists Troy ...
(Date:6/14/2017)... (PRWEB) , ... June 14, 2017 , ... The newest ... discover new therapeutic antibodies using rabbits that express human genes. ATGC, a spin out ... , Founded in 2015, ATGC is a translational genomics company. Its founders are ...
(Date:6/13/2017)... ... June 13, 2017 , ... ... Science Center’s Phase 1 Ventures (P1V) program. PolyCeramX, Recensa Therapeutics and Regennera, all ... commercialization activities. , Phase 1 Ventures is a startup accelerator that helps ...
(Date:6/13/2017)... ... June 13, 2017 , ... Presented at American Diabetes Association: ... disease-free patients who went on to develop chronic kidney disease within four years , ... the community and evaluated 792 patients over a four year period , ...
Breaking Biology Technology: